NeuroLINCS
Demographics (2)
- AGE - Subject age at sampling (phv00282627.v2.p1)
- SEX - Gender of participant (phv00282621.v2.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for ALS or SMA disease (phv00282614.v1.p1)
Race and Ethnicity (1)
- RACE - Race of participant (phv00282622.v2.p1)
Other (33)
- ANALYTE_TYPE - The analyte type of the sample (ex. DNA and RNA) (phv00282634.v2.p1)
- CELL_MARKERS - Antibody markers used to classify induced Pluripotent Stem Cell lines or motor neuron cell lines (phv00301410.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00282611.v1.p1)
- DIAGNOSIS - Clinical diagnosis (phv00282626.v2.p1)
- DIAGNOSIS_DETAIL - Gene mutated or subtype of disease diagnosis (phv00374953.v1.p1)
- FRAGMENT_SIZE - The size of the actual fragments submitted for sequencing after library size-selection. (phv00282637.v2.p1)
- HISTOLOGICAL_TYPE - Cell type samples were made from (phv00282630.v2.p1)
- IMN_DAYS_DIFFERENTIATION - How many days cells were differentiated into motor neurons (phv00301408.v1.p1)
- IPS_PASSAGE_NUMBER - Induced Pluripotent Stem Cell line Passage number used for assay (phv00282631.v2.p1)
- IS_TUMOR - The tumor status of the sample (phv00282643.v2.p1)
- LIBRARY_PREP_KIT - Kit used to prepare the library for sequencing (phv00282636.v2.p1)
- PROTOCOL - Protocol used by Cedars-Sinai Stem Cell Core Facility (phv00301409.v1.p1)
- RIN_VALUE - RNA integrity number (phv00282635.v2.p1)
- SAMPLE_ID - De-identified Sample ID (phv00282628.v2.p1)
- SAMPLE_ID - Sample ID (phv00282616.v2.p1)
- SAMPLE_SOURCE - Source Institution where samples originated (phv00282633.v2.p1)
- SAMPLE_SOURCE - Source of iPS cell line (phv00282618.v2.p1)
- SAMPLE_USE - Sample Use (phv00282617.v2.p1)
- SEQ_CYCLE_NUMBER - Number of sequencing cycles used (phv00282640.v2.p1)
- SEQ_PLATFORM - Company and instrument model used for sequencing (phv00282641.v2.p1)
- SEQ_TYPE - Defines the sequencing strategy. Paired-end sequences inserts in both directions, single-end sequences from one direction (phv00282638.v2.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00282642.v2.p1)
- SOURCE - Institution or repository from where the cell linewas obtained (phv00282624.v2.p1)
- SOURCE_ID - ID of source line (phv00282625.v2.p1)
- SOURCE_SAMPLE_ID - Sample ID used in center generating iPSC lines (phv00282619.v2.p1)
- SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00282613.v1.p1)
- SOURCE_TISSUE - Type of tissue (phv00282623.v2.p1)
- STRAND - Defines if a particular strand is sequenced (phv00282639.v2.p1)
- SUBJECT_ID - Subject ID (phv00282629.v2.p1)
- SUBJECT_ID - De-identified Subject ID (phv00282620.v2.p1)
- SUBJECT_ID - Subject ID (phv00282610.v1.p1)
- SUBJECT_ID - IPS cell line name (phv00282615.v2.p1)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00282612.v1.p1)